Concepedia

Publication | Open Access

Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma

43

Citations

33

References

2016

Year

Abstract

The described results provide a strong rationale for the clinical trials implemented in BRAF(V600E) melanoma patients with BRAF-I and IFNα combination.

References

YearCitations

Page 1